Initiation of sodium-glucose cotransporter-2 inhibitors at lower HbA1c threshold attenuates eGFR decline in type 2 diabetes patients with and without cardiorenal disease: A propensity-matched cohort study.
在較低的HbA1c閾值下開始使用鈉葡萄糖共轉運蛋白2抑製劑可減緩2型糖尿病患者腎臟過濾率下降，無論是否合併心腎疾病：一項傾向匹配的同期研究。
Diabetes Res Clin Pract 2023-02-10
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.
糖尿病患者合併慢性腎臟病，在使用鈉葡萄糖共同轉運蛋白2抑制劑前的身體質量指數對於達到目標血壓的影響。
Hypertens Res 2024-03-08
Predictors of weight reduction effectiveness of SGLT2 inhibitors in diabetes mellitus type 2 patients.
SGLT2抑制劑在2型糖尿病患者體重減輕效果的預測因子。
Front Endocrinol (Lausanne) 2024-02-28
Comparison of estimated glomerular filtration rate change with sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists among people with diabetes: A propensity-score matching study.
糖尿病患者中使用鈉葡萄糖共同轉運蛋白-2抑制劑與胰高血糖素樣肽-1受體激動劑對估計腎小球過濾率變化的比較：一項傾向性配對研究。
Diabetes Obes Metab 2024-03-26
Early reduction in albuminuria is associated with a steeper 'dip' in initial estimated glomerular filtration rate but favourable long-term kidney outcomes in people with diabetes receiving sodium-glucose cotransporter-2 inhibitors.
糖尿病患者早期蛋白尿減少與接受鈉葡萄糖共轉運輸蛋白2抑制劑者，初始估計腎小球過濾率下降較快但長期腎臟結果較佳相關。
Diabetes Obes Metab 2024-07-02
Effect of Sodium Glucose Co-Transporter 2 Inhibitor Use on Anthropometric Measurements and Blood Glucose in Obese and Non-Obese Type 2 Diabetic Patients.
鈉葡萄糖共轉運蛋白 2 抑制劑使用對肥胖及非肥胖 2 型糖尿病患者的人體測量和血糖的影響。
Clin Nutr ESPEN 2024-07-24
Retrospective analysis of the effect of SGLT-2 inhibitors on renal function in patients with type 2 diabetes in the real world.
SGLT-2 抑制劑對於真實世界中 2 型糖尿病患者腎功能影響的回顧性分析。
Front Pharmacol 2024-08-20
Association of initial serum sodium change and clinical outcome in patients with diabetes receiving sodium-glucose cotransporter-2 inhibitor therapy: A multicentre database analysis in Taiwan.
初始血清鈉變化與接受鈉-葡萄糖共轉運蛋白-2抑制劑治療的糖尿病患者臨床結果的關聯：台灣多中心數據庫分析。
Diabetes Obes Metab 2024-10-21
Sodium-glucose cotransporter 2 inhibitors and cardiovascular events among patients with type 2 diabetes and low-to-normal body mass index: a nationwide cohort study.
鈉-葡萄糖共轉運蛋白 2 抑制劑與體重指數低至正常的 2 型糖尿病患者心血管事件的關聯：一項全國性隊列研究。
Cardiovasc Diabetol 2024-10-22